CHU Dupuytren

Limosges 8 trials 3 recruiting

8 Registered trials

3 Currently recruiting

Organisation

CHU Dupuytren

Location

Limosges, France

Identifier

ORL-000004403

Address

2, avenue Martin Luther King, 87042, France

Departments

Chirurgie Viscérale et générale
Hématologie
Medecine interne
Oncologie
Oncologie médicale
oncology
Unité de Recherche Clinique, Hématologie Clinique et Thérapie Cellulaire

Clinical trials at this site (8)

Search interface

ENGIC 06 (PRODIGE 114) – FFCD 2401 – FRUQUITAS Randomized phase III trial to compare trifluridine/tipiracil + Fruquintinib versus triflurid… Recruiting

2025-522395-92-00 metastatic oeso-gastric adenocarcinoma 5 2025-12-15
Dose individualization of chemotherapy in patients with gastrointestinal cancers lacking a specific liver enzyme Recruiting

2023-509963-25-00 Fluoropyrimidine (FP)-naive patients with gastrointesti 4 2025-01-17
Hyperthermic Intraperitoneal Chemotherapy in the treatment of Ovarian Cancer relapse Recruiting

2024-517390-24-00 Ovarian epithelial cancer : intraperitoneal resectable 5 2011-04-26
Loc-R01: Randomized Phase IB/II Study of escalating doses of Lenalidomide and Ibrutinib in association with R-MPV as a targeted induction tr… Ended

2024-515331-30-00 Primary Central Nervous System Lymphoma (PCNSL) 7 2020-10-30
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free … Ended

2024-516198-61-00 Patients with high risk of relapse, ER+ and HER2- prima 5 2013-06-05
A 24-week with possible extension, prospective, multicenter, randomized, double blind, placebo-controlled, 2-parallel group with a randomiza… Halted

2024-514538-19-00 Mastocytosis 5 2025-11-26
Impact of neoadjuvant immunotherapy in early stage breast cancer before standard therapy (BIS-Program) Ended

2024-512826-26-00 Newly diagnosed, non-metastatic early-stage triple-nega 4 2022-03-07
IMPACT-CTEPH Ended

2024-513672-17-00 Inoperable Chronic thromboembolic pulmonary hyperTensio 4 2021-06-14